首页> 外文期刊>International archives of allergy and immunology >Serum Biomarkers of Allergic Contact Dermatitis: A Pilot Study
【24h】

Serum Biomarkers of Allergic Contact Dermatitis: A Pilot Study

机译:过敏性接触性皮炎的血清生物标志物:一项初步研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Allergic contact dermatitis (ACD) is an inflammatory skin disease caused by repeated skin exposure to contact allergens. The goal of this pilot study was to identify inflammatory proteins which can serve as biomarkers for ACD. Methods: We measured levels of 102 cytokines, chemokines, and growth factors in the sera of 16 ACD patients during acute and remission phases, and 16 healthy volunteers. Results: Serum levels of adiponectin, chemokine (C-C motif) ligand 5 (CCL5), C-reactive protein (CRP), chitinase 3-like 1 (CHI3L1), complement factor D (CFD), endoglin, lipocalin-2, osteopontin, retinol-binding protein 4 (RBP4), and platelet factor 4 (PF4) were significantly higher, whereas levels of trefoil factor 3 (TFF3) were significantly lower, in ACD patients than in healthy controls. In ACD patients, serum levels of CCL5 were elevated, whereas levels of TFF3, soluble intercellular adhesion molecule-1 (sICAM-1), and platelet derived growth factor (PDGF)-AB/BB were found to be lower during the remission phase of the disease. Conclusions: Serum levels of adiponectin, CCL5, CRP, CHI3L1, CFD, endoglin, lipocalin-2, osteopontin, RBP4, PF4, and TFF3 might be exploited as biomarkers for ACD, whereas levels of CCL5, TFF3, sICAM-1, and PDGF-AB/BB might be exploited for evaluation of disease progression and efficacy of ACD treatment. (C) 2016 S. Karger AG, Basel
机译:背景:过敏性接触性皮炎(ACD)是由反复接触皮肤接触过敏原引起的炎症性皮肤病。这项初步研究的目的是鉴定可以用作ACD生物标志物的炎症蛋白。方法:我们测量了16名ACD患者在急性期和缓解期的血清中102种细胞因子,趋化因子和生长因子的水平,以及16名健康志愿者。结果:血清脂联素,趋化因子(CC基序)配体5(CCL5),C反应蛋白(CRP),几丁质酶3样1(CHI3L1),补体因子D(CFD),内皮糖蛋白,脂蛋白2,骨桥蛋白,与健康对照组相比,ACD患者的视黄醇结合蛋白4(RBP4)和血小板因子4(PF4)显着较高,而三叶因子3(TFF3)的水平显着降低。在ACD患者中,血清CCL5升高,而TFF3,可溶性细胞间粘附分子1(sICAM-1)和血小板衍生生长因子(PDGF)-AB / BB的水平在ACD患者的缓解期较低。这种病。结论:脂联素,CCL5,CRP,CHI3L1,CFD,内皮糖蛋白,脂钙蛋白-2,骨桥蛋白,RBP4,PF4和TFF3的血清水平可作为ACD的生物标志物,而CCL5,TFF3,sICAM-1和PDGF -AB / BB可用于评估疾病进展和ACD治疗的疗效。 (C)2016 S.Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号